https://www.selleckchem.com/products/PLX-4032.html
6%) compared to autograft (8%-29%, I = 66.1%). Reoperation (0%-36%, I = 73.4%), revision surgeries (0%-21%, I = 81.2%), medical complications (0%-5%, I = 0.0%), and infections (0%-5%, I = 0.0%) were also calculated. SCR carries a distinct complication profile when used for the treatment of FIRCTs. The overall rate of complications ranged from 5.0% to 70.0%. The most common complication is graft retear with higher ranges in allografts (19%-70%) compared to autografts (8%-29%). The majority of studies reported at least 1 reoperation (ran
Like
Comment
Share
